She is Chief Financial Officer of Longboard Pharmaceuticals, Inc., and prior to Longboard, she served as Chief Financial Officer for the clinical-stage biotechnology company Lineage Cell Therapeutics, Inc. Before that, she was Chief Financial Officer at medical device company REVA Medical, Inc. She has also held positions at Mast Therapeutics, Inc., where she advanced from Senior Vice President of Finance to Chief Financial Officer. Previously, Brandi held senior positions at Alphatec Spine, Inc., Artes Medical, Inc., Stratagene Corporation, and Pfizer, Inc. Brandi currently serves as Chair of the Southern California Chapter of the Association of Bioscience Financial Officers. She is a certified public accountant with the State of California and received her BS degree in business administration from the University of Arizona and her MBA from the University of San Diego.